Authors:
Atkins, HB
Redman, B
Mier, J
Gollob, J
Weber, J
Sosman, J
MacPherson, BL
Plasse, T
Citation: Hb. Atkins et al., A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-desk interleukin-2 in patients with renal cancer and melanoma, CLIN CANC R, 7(3), 2001, pp. 486-492